Vaccination for COVID 19
Covid 2019 (coronavirus) is a related respiratory infection that causes various diseases in humans and other animals. The new covid 19 spreads through droplets generated by an infected person when they cough, sneeze, or through droplets of saliva (Khan 2020). It has been termed as a global pandemic that can be spread to hundreds of people in a chain of interrelation with each other. The most common symptoms, according to the world health organization, are breathing difficulties, fever, coughs, and shortness of breath. However, in severe cases, covid 19 infections may lead to pneumonia and even death. The world is at war with the pandemic that has increasingly raised the number of deaths globally every 24 hours.
Question 1. Objectives
A vaccine is a treatment that improves body immunity against infection. It involves showing the body immune system, something that’s similar to the particular virus hence helping the body to be stronger when fighting against the real infection. The most critical objective of vaccination is to improve the control of infectious diseases (Erbelding 2018. The company’s goal of people selection of new vaccination helps it to gain more familiarity with the phenomenon at hand and develop new insights into it. Secondly, information search on various people helps to determine the frequency with which infections are cured or with which they are related to other diseases (Tanaka 2018). People’s selection of new vaccination enables the company to test the hypothesis of causal relationships between variables of the virus. Don't use plagiarised sources.Get your custom essay just from $11/page
Question 2. Hypothesis
A hypothesis technically refers to a statement that tests the relationship between the dependent and independent variables that can be verified by scientific research. How effective would the new vaccine improve body immunity to covid 19? A new vaccination on covid 19 would reduce the number of deaths caused by infections by improving body immunity to fight against the infections. A new vaccination on covid 19 will not affect if people do not choose it as the most effective.
Questionnaire
This questionnaire is designed to collect data from patients about their selection of a new vaccination. The patient will not be required to write their name. Information received will be treated with confidentiality. Where applicable, use a tick.
- Bio Data
- What is your gender
- Male ( )
- Female ( )
- What is your age
i.17-18 years ( ) ii 18-30 years ( ) iii over 30 years ( )
- Patient Knowledge about vaccination
- In the table below, indicate your level of agreement as it relates to the following statements. Use YES, NO, UNCERTAIN to give your views.
| NO | STATEMENT | YES | NO | UNCERTAIN | COMMENT |
| 1 | Do people develop immunity? | ||||
| 2 | If humans develop immunity, how long does it last? | ||||
| 3 | Is the vaccine likely to work? | ||||
| 4 | Will it be safe? |
- How does your knowledge of vaccination influence your selection of the new vaccine?
————————————————————————————————————
————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Patient response on vaccination
In the table below, indicate your views as it relates to the following statements. Use YES, NO, and UNCERTAIN to give your views.
| NO | STATEMENT | YES | NO | UNCERTAIN |
| 1 | What is the effect of immune suppression on vaccination? | |||
| 2 | Can unvaccinated patients be denied treatment? | |||
| 3 | Is an immune serum and vaccination different? | |||
| 4 | Are pharmacists responsible for administering vaccines? |
- How does your knowledge of patient response on vaccination influence your choice of the new vaccine?
———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————–
References
Khan, N., Fahad, S., Naushad, M., and Muhammad, A., 2020. Explanation of Corona Virus Control Novel by Warm and Humid Seasons in the World. Available at SSRN 3561155.
Erbelding, E.J., Post, D.J., Stemmy, E.J., Roberts, P.C., Augustine, A.D., Ferguson, S., Paules, C.I., Graham, B.S. and Fauci, A.S., 2018. A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases. The Journal of infectious diseases, 218(3), pp.347-354.
Tanaka, J., Akita, T., Ohisa, M., Sakamune, K., Ko, K., Uchida, S., and Satake, M., 2018. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. Journal of viral hepatitis, 25(4), pp.363-372.